You’re standing at the dispensary counter, head pounding, eyes sensitive to the fluorescent lights above you, and the budtender asks: “Are you looking for indica or sativa?”
You say indica, because that’s what someone told you once. You go home, try it, and it kind of works. Or it doesn’t. Or it works this time but not the next.
Sound familiar?
Here’s the thing that question, “indica or sativa,” is probably the least useful way to shop for migraine relief. Not because cannabis doesn’t work for migraines. The research is actually pretty encouraging on that front. But because the indica/sativa framework was never built around your nervous system or your pain. It was built around how a plant looks.
Let’s talk about what actually matters.
The Label That’s Misleading You
Walk into any dispensary and you’ll see strains sorted into three buckets: indica (relaxing, body-heavy), sativa (uplifting, cerebral), and hybrid (somewhere in between). This system has been around so long it feels like science. It isn’t.
Cannabis researchers have known for years that these labels don’t reliably predict how a strain will affect you. What actually drives effects is the chemical profile specifically:
- Cannabinoids : THC, CBD, and a handful of lesser-known compounds that interact with your endocannabinoid system.
- Terpenes : the aromatic compounds that do far more than make cannabis smell interesting. They have real physiological effects and interact with cannabinoids in ways that shape your experience.
Two strains both labeled “indica” can have completely different terpene profiles and produce completely different results. For migraine sufferers especially, this matters. You’re not shopping for a vibe. You’re trying to manage a neurological event involving pain, nausea, light sensitivity, and sometimes a two-day recovery.
The Migraine Phase Framework (Most Guides Skip This)
A migraine is not a single moment of pain. It moves through four distinct phases and what helps during one phase can be useless, or even counterproductive, during another.
Phase 1 Prodrome (Hours Before the Headache)
Warning signs like neck stiffness, mood shifts, or unusual fatigue. This is your window to intervene early.
- What works: Low-dose CBD-forward products or mild 1:1 CBD-to-THC balanced options. Nothing heavy. The goal is to quiet neurological inflammation before it escalates without disrupting the rest of your day.
Phase 2 Aura (If You Experience It)
Visual disturbances, tingling, or sensory changes that signal the attack is imminent.
What works: Same as prodrome, low-dose and non-sedating. Some people find that a mild inhaled option at this stage helps blunt the severity of what comes next.
Phase 3 The Attack
The full headache, nausea, light and sound sensitivity. This is the phase most people are shopping for.
What works: Inhaled cannabis, smoked or vaporized for speed. Edibles take 30–90 minutes to kick in, which is too slow when you’re already in pain. Look for products rich in beta-caryophyllene and myrcene (more on these below). A balanced 2:1 THC-to-CBD ratio tends to be a sweet spot for pain relief without complete sedation.
Phase 4 Postdrome (The Migraine Hangover)
Fatigue, brain fog, lingering sensitivity. You’re not in acute pain, but you’re not okay either.
What works: Step the THC down significantly here. A heavy indica will deepen the fog, not lift it. Low-dose or CBD-dominant options help you recover and function without piling sedation on top of exhaustion.
What the Research Actually Says
The evidence is promising but worth reading honestly, without overstating it.
- On pain reduction: A 2020 study in the Journal of Pain found nearly a 50% reduction in migraine severity ratings associated with cannabis use.
- On frequency: Research has found that roughly two-thirds of regular medical cannabis users reported a decrease in how often migraines occurred over time.
- On CBD specifically: One clinical study found that patients using oral cannabis with very low THC (0.4%) and higher CBD (9%) experienced a 55% drop in pain severity during attacks, and a 40% reduction in headache frequency with daily use results comparable to the prescription drug amitriptyline. High THC is not the only path to relief, and for many people, it isn’t even the best one.
- The honest caveat: Heavy daily THC use can actually increase headache frequency in some people, a pattern sometimes called medication overuse headache, similar to what can happen with ibuprofen taken too often. More is not always better.
The Terpenes Worth Knowing
A 2018 study in The Journal of Headache and Pain identified the terpenes migraine patients consistently preferred. Here’s what each one does and when it matters:
-
Beta-Caryophyllene
Binds directly to CB2 receptors (unusual for a terpene) and helps regulate inflammation. Most relevant during active attacks. Look for this one on any COA.
-
Myrcene
Promotes relaxation, eases pain, and supports sleep. Heavy in most indica-leaning profiles. Best for the attack and recovery phases.
-
Linalool
Calms the nervous system. Most useful when stress or anxiety is a migraine trigger for you.
-
Limonene
Mood-lifting and anti-anxiety. Worth seeking out if emotional tension tends to precede your attacks.
-
Pinene
Mild anti-inflammatory and anxiety-reducing. Less potent than the above but a useful supporting compound.
These are the things actually worth asking about at the dispensary not whether something leans indica or sativa.
A Simple Decision Guide
- For prevention and early symptoms → CBD-dominant or 1:1 balanced products. Tinctures or low-dose edibles. Consistent, daily or near-daily use. Lowest risk, most evidence for frequency reduction.
- For active attacks → Inhaled for speed. High beta-caryophyllene and myrcene. 2:1 THC-to-CBD ratio as a starting point. Indica-leaning or balanced hybrid labels matter less than terpene content.
- For postdrome recovery → Step down the THC. CBD-forward or low-dose options. Prioritize function and sleep quality over sedation.
The One Question Worth Asking at the Dispensary
Skip “indica or sativa?” and ask this instead:
-
“What’s the terpene profile, and what’s the THC-to-CBD ratio?”
That question will either get you a far more useful answer, or tell you something telling about whether that dispensary actually knows what they’re selling.
Cannabis for migraines isn’t a guaranteed fix, and the research still has gaps. But for people who’ve cycled through pharmaceuticals with mixed results, it’s a real, thoughtful option, one that deserves more than a vibe-based answer from someone pointing at a shelf.
The indica/sativa question isn’t stupid. It’s just the wrong one.
